Jacobs Levy Equity Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $592K | Buy |
|
|||||
|
2025
Q2 | $223K | Sell |
|
|||||
|
2025
Q1 | $1.44M | Sell |
|
|||||
|
2024
Q4 | $4.13M | Sell |
|
|||||
|
2024
Q3 | $4.65M | Sell |
|
|||||
|
2024
Q2 | $4.97M | Buy |
|
|||||
|
2024
Q1 | $5M | Buy |
|
|||||
|
2023
Q4 | $4.43M | Sell |
|
|||||
|
2023
Q3 | $3.52M | Sell |
|
|||||
|
2023
Q2 | $6.18M | Sell |
|
|||||
|
2023
Q1 | $11M | Sell |
|
|||||
|
2022
Q4 | $11.6M | Buy |
|
|||||
|
2022
Q3 | $8.39M | Sell |
|
|||||
|
2022
Q2 | $7.79M | Sell |
|
|||||
|
2022
Q1 | $9.96M | Buy |
|
|||||
|
2021
Q4 | $11.3M | Buy |
|
|||||
|
2021
Q3 | $4.78M | Buy |
|
|||||
|
2021
Q2 | $8.59M | Buy |
|
|||||
|
2021
Q1 | $11.4M | Sell |
|
|||||
|
2020
Q4 | $10.1M | Sell |
|
|||||
|
2020
Q3 | $8.72M | Buy |
|
|||||
|
2020
Q2 | $10.2M | Buy |
|
|||||
|
2020
Q1 | $9.64M | Sell |
|
|||||
|
2019
Q4 | $11.7M | Buy |
|
|||||
|
2019
Q3 | $7.43M | Buy |
|
|||||
|
2019
Q2 | $5.06M | Buy |
|
|||||
|
2019
Q1 | $6.09M | Buy |
|
|||||
|
2018
Q4 | $4.47M | Buy |
|
|||||
|
2018
Q3 | $5.58M | Sell |
|
|||||
|
2018
Q2 | $4.49M | Buy |
|
|||||
|
2018
Q1 | $1.71M | Buy |
|
|||||
|
2017
Q4 | $432K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $479K | Buy |
|